Abstract
Nosocomial pneumonia is one of the most common healthcare-associated infections and the most frequent in intensive care unit (ICU) patients. The clinical and economic consequences of nosocomial pneumonia are very significant, especially for ventilated patients. In this article we present several clinical observations that demonstrate the difficulties of antibacterial therapy of nosocomial pneumonia and ventilator-associated pneumonia in adults in multidisciplinary hospitals in Moscow, which are due to both patient characteristics and profile of circulating pathogens.
I.M. Sechenov First Moscow State Medical University, Moscow, Russia
City Clinical Hospital named after S.S. Yudin, Moscow, Russia
Russian Medical Academy of Continuous Professional Education, Moscow, Russia
I.M. Sechenov First Moscow State Medical University, Moscow, Russia
I.M. Sechenov First Moscow State Medical University, Moscow, Russia
I.M. Sechenov First Moscow State Medical University, Moscow, Russia
I.M. Sechenov First Moscow State Medical University, Moscow, Russia
City Clinical Hospital named after S.S. Yudin, Moscow, Russia
Center for Strategic Planning and Management of Medical and Biological Health Risks, Moscow, Russia
City Clinical Hospital named after S.S. Yudin, Moscow, Russia
Russian Medical Academy of Continuous Professional Education, Moscow, Russia
City Clinical Hospital named after S.S. Yudin, Moscow, Russia
Hospital for War Veterans No. 3, Moscow, Russia
-
1.
Rachina S.A., Fedina L.V., Sukhorukova M.V., Sychev I.N., Larin E.S., Alkhlavov A.A. Diagnosis and antibiotic therapy of nosocomial pneumonia in adults: from recommendations to real practice. A review. Terapevticheskii arkhiv. 2023;95(11):996-1003. Russian.
DOI: 10.26442/00403660.2023.11.202467
-
2.
Gamazo J.J., Candel F.J., González Del Castillo J. Nosocomial pneumonia: current etiology and impact on antimicrobial therapy. Rev Esp Quimioter. 2023;36(Suppl. 1):9-14.
DOI: 10.37201/req/s01.03.2023
-
3.
Vezirova Z.Sh. Some aspects of nosocomial infections dissemination in intensive care units of different profile. Pirogov Russian journal of surgery. 2015;(3):93-96. Russian.
DOI: 10.17116/hirurgia2015393-96
-
4.
Rudnov V.A., Belsky D.V., Dehnich A.V., RIORIT Research Group. Infections in Russian ORITs: results of a national multicenter study. Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2011;13(4):294-303. Russian.
-
5.
Berton D.C., Kalil A.C., Teixeira P.J.Z. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev. 2014;30:(10):CD006482.
DOI: 10.1002/14651858.CD006482.pub4
-
6.
Torres A., Niederman M.S., Chastre J., Ewig S., FernandezVandellos P., Hanberger H., et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospitalacquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017;50(3):1700582.
DOI: 10.1183/13993003.00582-2017
-
7.
Kalil A.C., Metersky M.L., Klompas M., Muscedere J., Sweeney D.A., Palmer L.B., et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61-e111.
DOI: 10.1093/cid/ciw353
-
8.
Zaragoza R., Vidal-Cortés P., Aguilar G., Borges M., Diaz E., Ferrer R., et al. Update of the treatment of nosocomial pneumonia in the ICU. Crit Care. 2020;24(1):383.
DOI: 10.1186/s13054-020-03091-2
-
9.
Giuliano K.K., Baker D., Quinn B. The epidemiology of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control. 2018;46(3):322-327.
DOI: 10.1016/j.ajic.2017.09.005
-
10.
Kuzmenkov A.Yu., Trushin I.V., Avramenko A.A., Edelstein M.V., Dekhnich A.V., Kozlov R.S. AMRmap: an online platform for monitoring antibiotic resistance. Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2017;19(2):84-90. Russian.
-
11.
Liu P., Li X., Luo M., Xu X., Su K., Chen S., et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis. Microb Drug Resist. 2018;24(2):190-198.
DOI: 10.1089/mdr.2017.0061
-
12.
Tsolaki V., Mantzarlis K., Mpakalis A., Malli E., Tsimpoukas F., Tsirogianni A., et al. Ceftazidime-avibactam to treat life-threatening infections by carbapenem-resistant pathogens in critically ill mechanically ventilated patients. Antimicrob Agents Chemother. 2020;64(3):e02320-19.
DOI: 10.1128/AAC.02320-19
-
13.
Zhen S., Wang H., Feng S. Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gramnegative bacteria infections. Infection. 2022;50(6):1409-1423.
DOI: 10.1007/s15010-022-01876-x
-
14.
Beloborodov V.B., Goloschapov O.V., Gusarov V.G., Dekhnich А.V., Zamyatin M.N., Zubareva N.A., et al. Guidelines of the Association of AnesthesiologistsIntensivists, the Interregional Non-Governmental Organization Alliance of Clinical Chemotherapists and Microbiologists, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and NGO Russian Sepsis Forum "Diagnostics and antimicrobial therapy of the infections caused by multiresistant microorganisms" (update 2022). Messenger of anesthesiology and resuscitation. 2022;19(2):84-114. Russian.
DOI: 10.21292/2078-5658-2022-19-2-84-114
-
15.
Falcone M., Daikos G.L, Tiseo G., Bassoulis D., Giordano C., Galfo V., et al. Efficacy of ceftazidimeavibactam plus aztreonam in patients with bloodstream infections caused by metallo-β-lactamase-producing Enterobacterales. Clin Infect Dis. 2021;72(11):1871-1878.
DOI: 10.1093/cid/ciaa586
-
16.
Taha R., Kader O., Shawky S., Rezk S. Ceftazidimeavibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope. Ann Clin Microbiol Antimicrob. 2023;22(1):21.
DOI: 10.1186/s12941-023-00573-3
-
17.
Bussini L., Pascale R., Rinaldi M., Bartoletti M. Diagnosis, management and treatment of nosocomial pneumonia in ICU: a narrative review. J Emerg Crit Care Med. 2022;6:25.
DOI: 10.21037/jeccm-22-32
-
18.
Paul M., Carrara E., Retamar P, Tängdén T., Bitterman R., Bonomo R.A., et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine). Clin Microbiol Infect. 2022;28(4):521-547.
DOI: 10.1016/j.cmi.2021.11.025
-
19.
Tamma P.D., Aitken S.L., Bonomo R.A., Mathers A.J., van Duin D., Clancy C.J. Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections. Clin Infect Dis. 2023;ciad428.
DOI: 10.1093/cid/ciad428